Financial results - SUHARD BIOMEDICAL S.R.L.

Financial Summary - Suhard Biomedical S.r.l.
Unique identification code: 43952188
Registration number: J2021000378063
Nace: 4646
Sales - Ron
447.528
Net Profit - Ron
218.543
Employees
1
Open Account
Company Suhard Biomedical S.r.l. with Fiscal Code 43952188 recorded a turnover of 2024 of 447.528, with a net profit of 218.543 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Suhard Biomedical S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - 14 4.090 55.737 447.528
Total Income - EUR - - - - - - 15 4.090 55.737 447.714
Total Expenses - EUR - - - - - - 63 3.542 46.417 216.947
Gross Profit/Loss - EUR - - - - - - -49 548 9.320 230.768
Net Profit/Loss - EUR - - - - - - -49 508 8.016 218.543
Employees - - - - - - 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 707.4%, from 55.737 euro in the year 2023, to 447.528 euro in 2024. The Net Profit increased by 210.571 euro, from 8.016 euro in 2023, to 218.543 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Suhard Biomedical S.r.l.

Rating financiar

Financial Rating -
SUHARD BIOMEDICAL S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Suhard Biomedical S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Suhard Biomedical S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Suhard Biomedical S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Suhard Biomedical S.r.l. - CUI 43952188

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - 0 0 0 259.217
Current Assets - - - - - - 1.141 2.040 14.033 172.406
Inventories - - - - - - 944 644 334 93.637
Receivables - - - - - - 105 0 6.384 70.036
Cash - - - - - - 93 1.396 7.315 8.733
Shareholders Funds - - - - - - -9 499 8.514 218.591
Social Capital - - - - - - 40 41 40 40
Debts - - - - - - 1.150 1.541 5.519 213.032
Income in Advance - - - - - - 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 172.406 euro in 2024 which includes Inventories of 93.637 euro, Receivables of 70.036 euro and cash availability of 8.733 euro.
The company's Equity was valued at 218.591 euro, while total Liabilities amounted to 213.032 euro. Equity increased by 210.125 euro, from 8.514 euro in 2023, to 218.591 in 2024.

Risk Reports Prices

Reviews - Suhard Biomedical S.r.l.

Comments - Suhard Biomedical S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.